Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant in refractory chronic cough
jRCT1041230149Completed
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of gefapixant in refractory chronic cough (RCC). Primary endpoints: Change in cough threshold and Change in bronchial smooth muscle contraction-induced cough count. Started Aug 2024; status: completed.
02
Drugs
gefapixant
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on jRCT1041230149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041230149.